EDGAR Filing Documents for 0001493152-21-012042

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001493152-21-012042

Filing Date

2021-05-18

Accepted

2021-05-18 06:10:30

Documents

Period of Report

2021-03-31

Document Format Files

Seq	Description	Document	Type	Size
1		form10-q.htm	10-Q	1086672
2		ex10-3.htm	EX-10.3	109981
3		ex10-8.htm	EX-10.8	93231
4		ex10-9.htm	EX-10.9	53174
5		ex10-10.htm	EX-10.10	48407
6		ex10-11.htm	EX-10.11	55169
7		ex10-12.htm	EX-10.12	19498
8		ex10-13.htm	EX-10.13	60151
9		ex10-14.htm	EX-10.14	10752
10		ex10-15.htm	EX-10.15	11933
11		ex10-16.htm	EX-10.16	19733
12		ex10-17.htm	EX-10.17	47931
13		ex10-18.htm	EX-10.18	27656
14		ex10-19.htm	EX-10.19	12142
15		ex31-1.htm	EX-31.1	18025
16		ex31-2.htm	EX-31.2	18464
17		ex32-1.htm	EX-32.1	6559
18		ex32-2.htm	EX-32.2	6229
19		ex99-1.htm	EX-99.1	190910
20		ex99-2.htm	EX-99.2	208949
21		ex99-3.htm	EX-99.3	568126
	Complete submission text file	0001493152-21-012042.txt		8159780

Data Files

Seq	Description	Document	Type	Size
22	XBRL INSTANCE FILE	mymd-20210331.xml	EX-101.INS	1014373
23	XBRL SCHEMA FILE	mymd-20210331.xsd	EX-101.SCH	117192
24	XBRL CALCULATION FILE	mymd-20210331_cal.xml	EX-101.CAL	79870
25	XBRL DEFINITION FILE	mymd-20210331_def.xml	EX-101.DEF	477601
26	XBRL LABEL FILE	mymd-20210331_lab.xml	EX-101.LAB	567876
27	XBRL PRESENTATION FILE	mymd-20210331_pre.xml	EX-101.PRE	482742

Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205

Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698

MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)